Fucoidan from Fucus vesiculosus: Evaluation of the Impact of the Sulphate Content on Nanoparticle Production and Cell Toxicity

被引:6
|
作者
Florez-Fernandez, Noelia [1 ,2 ,3 ]
Pontes, Jorge F. [1 ]
Guerreiro, Filipa [1 ]
Afonso, Ines T. [1 ]
Lollo, Giovanna [4 ]
Torres, Maria Dolores [2 ,3 ]
Dominguez, Herminia [2 ,3 ]
da Costa, Ana M. Rosa [5 ,6 ]
Grenha, Ana [1 ,7 ]
机构
[1] Univ Algarve, Fac Sci & Technol, Ctr Marine Sci CCMAR, Drug Delivery Lab, P-8005139 Faro, Portugal
[2] Univ Vigo, CINBIO, Orense 32004, Spain
[3] Univ Vigo, Fac Ciencias, Dept Ingn Quim, Grp Biomasa & Desarrollo Sostenible EQ 2, Orense 32004, Spain
[4] Univ Claude Bernard Lyon 1, Univ Lyon, LAGEPP CNRS, UMR 5007, F-69622 Villeurbanne, France
[5] Univ Algarve, Fac Sci & Technol, Algarve Chem Res Ctr CIQA, P-8005139 Faro, Portugal
[6] Univ Algarve, Fac Sci & Technol, Dept Chem & Pharm, P-8005139 Faro, Portugal
[7] Univ Lisbon, Res Inst Med iMed, Fac Pharm, Ave Prof Gama Pinto, P-1649003 Lisbon, Portugal
关键词
antioxidant; cell proliferation; chitosan; fucoidan; Fucus vesiculosus; nanoparticles; rheology; BROWN SEAWEED SARGASSUM; CHITOSAN NANOPARTICLES; MOLECULAR-WEIGHT; POLYSACCHARIDES; EXTRACTION; DELIVERY; MUTICUM; PH;
D O I
10.3390/md21020115
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The composition of seaweeds is complex, with vitamins, phenolic compounds, minerals, and polysaccharides being some of the factions comprising their structure. The main polysaccharide in brown seaweeds is fucoidan, and several biological activities have been associated with its structure. Chitosan is another marine biopolymer that is very popular in the biomedical field, owing to its suitable features for formulating drug delivery systems and, particularly, particulate systems. In this work, the ability of fucoidan to produce nanoparticles was evaluated, testing different amounts of a polymer and using chitosan as a counterion. Nanoparticles of 200-300 nm were obtained when fucoidan prevailed in the formulation, which also resulted in negatively charged nanoparticles. Adjusting the pH of the reaction media to 4 did not affect the physicochemical characteristics of the nanoparticles. The IC50 of fucoidan was determined, in both HCT-116 and A549 cells, to be around 160 mu g/mL, whereas it raised to 675-100 mu g/mL when nanoparticles (fucoidan/chitosan = 2/1, w/w) were tested. These marine materials (fucoidan and chitosan) provided features suitable to formulate polymeric nanoparticles to use in biomedical applications.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Antioxident, immunomodulatory and anticancer activity of fucoidan isolated from Fucus vesiculosus
    Han, Jae Gun
    Syed, Abdul Qadir
    Kwon, Minchul
    Ha, Ji Hye
    Lee, Hyeon Yong
    [J]. JOURNAL OF BIOTECHNOLOGY, 2008, 136 : S571 - S571
  • [2] Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus
    Zayed, Ahmed
    Hahn, Thomas
    Finkelmeier, Doris
    Burger-Kentischer, Anke
    Rupp, Steffen
    Kraemer, Roland
    Ulber, Roland
    [J]. PROCESS BIOCHEMISTRY, 2019, 81 : 182 - 187
  • [3] Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment
    Mathew, Lata
    Burney, Maryam
    Gaikwad, Anjali
    Nyshadham, Pranavand
    Nugent, Elizabeth K.
    Gonzalez, Anneliese
    Smith, Judith A.
    [J]. INTEGRATIVE CANCER THERAPIES, 2017, 16 (04) : 572 - 584
  • [4] Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment
    Bovet, Luc
    Samer, Caroline
    Daali, Youssef
    [J]. INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [5] Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo
    Wang, Lingzhi
    Oliveira, Catarina
    Li, Qiu
    Ferreira, Andreia S.
    Nunes, Claudia
    Coimbra, Manuel A.
    Reis, Rui L.
    Martins, Albino
    Wang, Chunming
    Silva, Tiago H.
    Feng, Yanxian
    [J]. MARINE DRUGS, 2023, 21 (05)
  • [6] Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro
    Durig, J
    Bruhn, T
    Zurborn, KH
    Gutensohn, K
    Bruhn, HD
    Beress, L
    [J]. THROMBOSIS RESEARCH, 1997, 85 (06) : 479 - 491
  • [7] Differential effects of Fucus vesiculosus fucoidan on fibroblast and macrophage cell lines inflammatory activation
    Augustyniak, Aleksandra
    Przyborska, Joanna
    Mcmahon, Helena
    [J]. RESULTS IN CHEMISTRY, 2024, 7
  • [8] Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
    Pozharitskaya, Olga N.
    Shikov, Alexander N.
    Faustova, Natalya M.
    Obluchinskaya, Ekaterina D.
    Kosman, Vera M.
    Vuorela, Heikki
    Makarov, Valery G.
    [J]. MARINE DRUGS, 2018, 16 (04):
  • [9] Fucoidan from Fucus vesiculosus Fails to Improve Outcomes Following Intracerebral Hemorrhage in Mice
    Burchell, Sherrefa R.
    Iniaghe, Loretta O.
    Zhang, John H.
    Tang, Jiping
    [J]. BRAIN EDEMA XVI: TRANSLATE BASIC SCIENCE INTO CLINICAL PRACTICE, 2016, 121 : 191 - 198
  • [10] Physicochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography
    Zayed, Ahmed
    Muffler, Kai
    Hahn, Thomas
    Rupp, Steffen
    Finkelmeier, Doris
    Burger-Kentischer, Anke
    Ulber, Roland
    [J]. MARINE DRUGS, 2016, 14 (04)